Serological based monitoring of a cohort of patients with chronic Chagas
disease treated with benznidazole in a highly endemic area of northern
Argentina

Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina

This study aimed to evaluate well-documented diagnostic antigens, named B13, 1F8 and JL7 recombinant proteins, as potential markers of seroconversion in treated chagasic patients. Prospective study, involving 203 patients treated with benznidazole, was conducted from endemic areas of northern Argent...

Full description

Bibliographic Details
Main Authors:	Niborski, Leticia L, Grippo, Vanina, Lafón, Sonia O, Levitus, Gabriela, García-Bournissen, Facundo, Ramirez, Juan C, Burgos, Juan M, Bisio, Margarita, Juiz, Natalia A, Ayala, Vilma, Coppede, María, Herrera, Verónica, López, Crescencia, Contreras, Ana, Gómez, Karina A, Elean, Juan C, Mujica, Hugo D, Schijman, Alejandro G, Levin, Mariano J, Longhi, Silvia A
Format:	Online
Language:	English
Published:	Instituto Oswaldo Cruz, Ministério da Saúde 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909034/

Similar Items

Benznidazole Treatment of Chagasic Encephalitis in Pregnant Woman with AIDS
by: Bisio, Margarita, et al.
Published: (2013)

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
by: Fernández, Marisa Liliana, et al.
Published: (2016)

Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults
by: Altcheh, Jaime, et al.
Published: (2014)

Prevention of congenital Chagas through treatment of girls and women of childbearing age
by: Moscatelli, Guillermo, et al.
Published: (2015)

Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments
by: Diniz, Lívia de Figueiredo, et al.
Published: (2013)

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil
by: Ferreira, Ariela Mota, et al.
Published: (2016)

Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease
by: Fragata-Filho, Abilio Augusto, et al.
Published: (2016)

Preclinical pharmacokinetics of benznidazole.
by: Workman, P., et al.
Published: (1984)

Quality of Reporting and Adherence to ARRIVE Guidelines in Animal Studies for Chagas Disease Preclinical Drug Research: A Systematic Review
by: Gulin, Julián Ernesto Nicolás, et al.
Published: (2015)

Ruthenium Complex with Benznidazole and Nitric Oxide as a New Candidate for the Treatment of Chagas Disease
by: Sesti-Costa, Renata, et al.
Published: (2014)

Clinical Follow-Up of Responses to Treatment with Benznidazol in Amazon: A Cohort Study of Acute Chagas Disease
by: Pinto, Ana Yecê das Neves, et al.
Published: (2013)

Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease
by: Assíria Fontes Martins, Tassiane, et al.
Published: (2015)

Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease
by: Vilar-Pereira, Glaucia, et al.
Published: (2016)

A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention
by: Machado-de-Assis, Girley Francisco, et al.
Published: (2013)

Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease
by: de Oliveira-Silva, Jaquelline Carla Valamiel, et al.
Published: (2015)

RELACIÓN ENTRE LOS GENOTIPOS DE T. CRUZI Y LA PRESENTACIÓN CLÍNICA DE LA ENFERMEDAD DE CHAGAS
by: Carolina Cura, et al.
Published: (2013-01-01)

Up-regulation of ATP-binding cassette transporters in the THP-1 human macrophage cell line by the antichagasic benznidazole
by: Perdomo, Virginia G, et al.
Published: (2016)

The role of light in Chagas disease infection risk in Colombia
by: Erazo, Diana, et al.
Published: (2016)

Regulation of Biotransformation Systems and ABC Transporters by Benznidazole in HepG2 Cells: Involvement of Pregnane X-Receptor
by: Rigalli, Juan P., et al.
Published: (2012)

Urban Chagas disease in children and women in primary care centres in Buenos Aires, Argentina
by: Moscatelli, Guillermo, et al.
Published: (2015)

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
by: Zingales, Bianca, et al.
Published: (2014)

Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
by: Batista, Denise da Gama Jaén, et al.
Published: (2011)

Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concert☆
by: Campos, Mônica C.O., et al.
Published: (2014)

Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
by: Trochine, Andrea, et al.
Published: (2014)

Environmental Changes Can Produce Shifts in Chagas Disease Infection Risk
by: Cordovez, Juan M, et al.
Published: (2014)

Una mirada a la integración de los valores desde el rol de las TIC
by: Marisa Cecilia Tumino, et al.
Published: (2017-01-01)

Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with trypanosoma cruzi antigens
by: Sathler-Avelar, Renato, et al.
Published: (2012)

Access to Chagas disease treatment in non-endemic countries: the case of Spain
by: Miriam Navarro, et al.
Published: (2017-06-01)

CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973]
by: Quiros, Franklin R, et al.
Published: (2006)

Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin
by: Campos-Estrada, Carolina, et al.
Published: (2015)

Hepatotoxicity in Mice of a Novel Anti-parasite Drug Candidate Hydroxymethylnitrofurazone: A Comparison with Benznidazole
by: Davies, Carolina, et al.
Published: (2014)

Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease
by: Castro-Sesquen, Yagahira E., et al.
Published: (2014)

Modeling the effects of palm-house proximity on the theoretical risk of Chagas disease transmission in a rural locality of the Orinoco basin, Colombia
by: Erazo, Diana, et al.
Published: (2016)

Chagas Disease
by: Tustin, Aaron W., et al.
Published: (2016)

Benznidazole Therapy Modulates Interferon-γ and M2 Muscarinic Receptor Autoantibody Responses in Trypanosoma cruzi-Infected Children
by: Cutrullis, Romina A., et al.
Published: (2011)

Host-parasite interaction: changes in human placental gene expression induced by Trypanosoma cruzi
by: Christian Castillo, et al.
Published: (2018-08-01)

Seroprevalence of Chagas Infection in the Donor Population
by: Zaniello, Ben A., et al.
Published: (2012)

Chagas’ disease: an update on immune mechanisms and therapeutic strategies
by: Boscardin, Silvia Beatriz, et al.
Published: (2010)

Molecular Epidemiology of Human Oral Chagas Disease Outbreaks in Colombia
by: Ramírez, Juan David, et al.
Published: (2013)

Treatment of Chagas Cardiomyopathy
by: Botoni, Fernando A., et al.
Published: (2013)